Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tirapazamine in Advanced Squamous Head and Neck Cancer
NCT00002774Phase 2Completed
- Sponsor
- Stanford University
- Start
- Jun 1996
- Primary completion
- Jun 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tirapazamine in squamous cell carcinoma of the head and neck (HNSCC), sponsored by Stanford University. Started Jun 1996; status: completed.
02
Drugs
tirapazamine
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00002774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002774.